Home › Trial NCT00270452
Safety of Peptide Vaccination for Patients With Myelodysplastic Syndrome
- Trial IDNCT00270452
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorNational Heart, Lung, and Blood Institute (NHLBI)
- Enrollment9
- Start date2005-12-22
- ConditionsMyelodysplastic Syndrome (MDS)
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.